{"id":"NCT02784704","sponsor":"Tetraphase Pharmaceuticals, Inc","briefTitle":"Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections","officialTitle":"A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10-13","primaryCompletion":"2017-05-08","completion":"2017-05-19","firstPosted":"2016-05-27","resultsPosted":"2019-02-18","lastUpdate":"2022-01-06"},"enrollment":500,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Complicated Intra-abdominal Infections","Complicated Appendicitis"],"interventions":[{"type":"DRUG","name":"Eravacycline","otherNames":["TP-434"]},{"type":"DRUG","name":"Meropenem","otherNames":["Merrem"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Eravacycline","type":"EXPERIMENTAL"},{"label":"Meropenem","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy, safety, and pharmacokinetics (PK) of eravacycline compared with meropenem in the treatment of complicated intra-abdominal infections (cIAIs).","primaryOutcome":{"measure":"Number of Participants With a Favorable Clinical Response at the Test-of-Cure (TOC) Visit in the Microbiological Intent-to-treat (Micro-ITT) Population","timeFrame":"TOC visit: 25-31 days after first dose of study drug","effectByArm":[{"arm":"Eravacycline","deltaMin":177,"sd":null},{"arm":"Meropenem","deltaMin":187,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":13},"locations":{"siteCount":54,"countries":["United States","Bulgaria","Czechia","Estonia","Georgia","Hungary","Latvia","Lithuania","Romania","Russia","Ukraine"]},"refs":{"pmids":["30561562","31570004"],"seeAlso":["https://www.ncbi.nlm.nih.gov/pubmed/?term=30561562"]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":250},"commonTop":["Nausea","Vomiting","Infusion site phlebitis"]}}